SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

The community is debating the company's lack of major contract awards following recent growth conferences, with bearish sentiment driven by skepticism toward leadership and missed performance expectations in military competitions. While some traders remain optimistic about long-term potential in the drone sector and the possibility of upcoming defense orders, others view the stock as a hype-driven play hampered by execution failures.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

Discussion is fragmented as traders express frustration over the ongoing decline in share price, citing dilution, insider selling, and concerns about company leadership. While some investors emphasize the long-term potential of the company's AI technology and recent acquisition, others remain skeptical, frequently referencing high short interest and lack of clear market catalysts.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is facing intense selling pressure and trading near 52-week lows, with investors debating whether the stock represents a deep-value buy or a structurally failing business amid concerns over weak restaurant traffic, high pricing, and shifting consumer preferences. While some traders view the decline as a generational buying opportunity for a dividend-paying blue chip, others remain bearish, citing poor execution and an uncompetitive fast-food landscape.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solar is trending as traders analyze the impact of potential new U.S. tariffs on polysilicon and China-manufactured energy equipment, which analysts believe could enhance the pricing power of domestic manufacturers. Investors are also responding to positive analyst upgrades and recent earnings performance, maintaining a debate over the stock's valuation versus policy-driven growth.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood shares have faced significant selling pressure following the Senate's rejection of the CLARITY Act, which aimed to establish a regulatory framework for digital assets, alongside reports that two former employees were charged with insider trading related to crypto listings. While retail sentiment remains largely bearish, some traders are pointing to the company's strong recent operating metrics and potential buying opportunities as reasons to accumulate shares on the pullback.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as the community anticipates potential guidance updates and upcoming Phase 2 NSCLC trial data, with traders highlighting strong commercial momentum for Amtagvi and a clear path to profitability. While the stock has seen significant momentum, sentiment remains bullish with discussions focused on institutional accumulation and the long-term potential of the company's solid tumor platform.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is experiencing downward pressure following market-wide concerns regarding a potential slowdown in the development of frontier AI models, despite some traders interpreting the pullback as a buying opportunity given continued long-term infrastructure demand. The conversation remains split between those fearing a broader AI bubble correction and others who maintain that capital expenditures for AI hardware will remain resilient.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

Valero Energy is trending as investors monitor ongoing supply constraints, including refinery outages and Middle East instability, which are keeping crack spreads elevated and supporting strong profitability. The community remains largely bullish, focusing on the company's robust refining margins and capital return programs, while also debating the long-term impact of potential fuel export policies and geopolitical risks.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is trending as shares rally past the double-digit mark, driven by strong sentiment regarding its recent Thailand expansion, growth in CME Nano futures, and anticipation of short-covering. Investors are closely watching for sustained support above the newly conquered $10 level, debating whether this strength signals a broader trend or a potential setup for a pullback.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is trending as the community highlights its strong momentum, fueled by a record backlog and rising demand for power infrastructure and grid modernization to support AI data centers. Investors are debating the company's valuation and volatility ahead of upcoming earnings, while some express frustration over recent intraday price swings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TG Therapeutics is trending due to renewed market speculation regarding a potential buyout, which has been fueled by circulating rumors of interest from a larger biopharma company. While investors debate the credibility of these reports and the potential valuation, the conversation also centers on the company's strong commercial momentum and the upcoming trial data for its subcutaneous treatment.

Kymera Therapeutics (KYMR) Up 10.2% Since Last Earnings Report: Can It Continue?

Kymera Therapeutics (KYMR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

TG Therapeutics (TGTX) Up 15.1% Since Last Earnings Report: Can It Continue?

TG Therapeutics (TGTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

TGTX Stock Pares Opening Losses After Analyst Dismisses Competition From Novartis 

Equity

TGTX shares opened lower on Tuesday after Novartis said its drug remibrutinib improved multiple sclerosis in late-stage trials. 


TGTX Stock On Track For Best Day In 3.5 Months Amid Fresh Buyout Rumors 

The mergers and acquisitions-focused blog Betaville published an alert on Friday signaling fresh interest from an unnamed suitor for TG Therapeutics, Seeking Alpha reported.


TG Therapeutics (TGTX) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS platform to develop in vivo gene editing therapies for high unmet need diseases, today reported financial results for the second quarter ended June 30, 2026, and provided a...

TGTX Q2 Earnings Lag, Sales Rise Y/Y, 2026 View Raised, Stock Down

TG Therapeutics misses Q2 earnings estimates, but surging Briumvi demand lifts revenues y/y and prompts higher 2026 revenue guidance. Stock falls.

Here's What Key Metrics Tell Us About TG Therapeutics (TGTX) Q2 Earnings

The headline numbers for TG Therapeutics (TGTX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

TG Therapeutics CEO Says Briumvi Is On Track To Become A $1B US Drug – Retail Shrugs Off EPS Miss 

The biotech firm increased its 2026 total global revenue target to around $950 million, up from $925 million previously.


TG Therapeutics (TGTX) Misses Q2 Earnings Estimates

TG Therapeutics (TGTX) delivered earnings and revenue surprises of -87.81% and +4.08%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. For more information, visit www.tgtherapeutics.com, and follow us on X (formerly Twitter) @TGTherapeutics and on LinkedIn.

TG Therapeutics Inc

Neutral Sentiment

Hike and the market rallies

Hike and the market falls

No change and the market rallies

No change and the market falls

The Federal Reserve's rate decision lands today at 2:00 PM ET. What do you think the Fed decides today, and how does the market react afterward? Vote and explain your reasoning in the comments.

What do you think the Fed decides today, and how does the market react? 
 
Drop a comment with the percentage move you expect.

Current Price	$56.20
Prev Close	$53.04
Open	$53.14
Dividend Yield	0.00%
50-Day Moving Average	$53.55
Beta	0.90
Avg. Volume	2.18M
PE Ratio	19.32

52-Week High	$59.30
52-Week Low	$26.76
Market Capitalization	$8.12B
EPS (Annual)	$2.77
Price to Book	13.44
Revenue Per Employee	$1.54M

Feed

News

Sentiment

Earnings

Fundamentals

Info

TGTX Fundamentals